MediPharm Labs Reports Strong, Profitable 2019 Third Quarter While Investing for Future Global Advantage Revenue $43.4 million, adjusted EBITDA $10.1 million BARRIE, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and purification, today […]

Continue reading…

Trending stories from over 100 sources, YouTube and Twitter
Our archive contains 44,278 news items. 292 articles added this week.